Compare Stryker Corporation (SYK) vs iShares Broad USD Investment Grade Corporate Bond (USIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Stryker Corporation vs iShares Broad USD Investment Grade Corporate Bond — how do they compare? Stryker Corporation trades at $346.82 (market cap $133.54B), while iShares Broad USD Investment Grade Corporate Bond trades at $50.25. The key difference: Stryker Corporation pays a 1.01% dividend while iShares Broad USD Investment Grade Corporate Bond pays none, and Stryker Corporation is trading nearer its 52-week high, iShares Broad USD Investment Grade Corporate Bond nearer its low. Which is the better fit depends on your goals.
| SYK | USIG | |
|---|---|---|
Market Cap | $133.54B | — |
Sector | Technology | Fixed Income |
52-Week High | $394.34 | $52.69 |
52-Week Low | $282.58 | $50.18 |
Enterprise Value | $145.01B | — |
Dividend Yield | 1.01% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Stryker (SYK) trades at $347.21, up 0.4% today, with a bullish technical outlook supported by moving averages. The stock shows strong fundamentals, including a 9% organic sales growth in Q2 2026 and a net income margin of 14.43%. Recent news highlights recovery from a cybersecurity incident and the launch of Mako RPS, expanding its robotic surgery portfolio. Analyst consensus is overwhelmingly positive, with 74% recommending Buy and a price target of $379.44.
The outlook for SYK is favorable, driven by robust earnings growth and strategic product launches. Key risks include cybersecurity vulnerabilities and margin pressures from tariffs. With no sell ratings and strong institutional support, the stock presents a compelling opportunity for growth-oriented investors, though monitoring quarterly execution remains critical.
USIG trades at $50.25, up 0.14% on the day, with a bearish technical signal driven by moving averages and neutral oscillators. Recent news includes a transaction with Tiptree Inc. and increased institutional interest from Bank of New York Mellon Corp. The stock shows consistent dividend payments, with three recent distributions totaling $0.62 per share through mid-2026.
The outlook remains cautious due to weak technical momentum and limited fundamental data visibility. Risks include reliance on corporate bond market stability and competitive pressures in the insurance sector. Analyst sentiment is neutral, with institutional accumulation suggesting long-term confidence amid near-term headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →About iShares Broad USD Investment Grade Corporate Bond
USIG is a low-cost ETF providing broad exposure to over 11,000 U.S. investment-grade corporate bonds. It tracks the ICE BofA US Corporate Index, featuring high-quality debt from 2026 leaders like Citigroup, Bank of America, and Oracle.
Read more on USIG →
